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Abstract 
Image guided technique is playing an increasingly important role in the investigation of the 
biodistribution and pharmacokinetics of drugs or drug delivery systems. The application of 
these new materials and techniques with combined properties of diagnosis and therapy can 
benefit the development of targeted drug delivery system and modern personalized medicine 
This special issue provides an up-to-date collection of original research articles and review on 
the development of novel targeted drug and drug delivery systems combining with 
non-invasive image guided techniques for chemotherapeutic reagents or DNA delivery. 
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Many routinely used therapeutic agents suffer 
from properties of poor pharmacokinetics and inap-
propriate biodistribution. After trying various differ-
ent passively and actively targeted delivery strategies 
over the years, the efficient delivery of a drug to its 
designated site of action is still facing challenges, es-
pecially in cancer chemotherapy, DNA or protein de-
livery. For example, because of the low molecular 
weight, drugs are rapidly cleared out from circulation; 
since the high hydrophobicity, many drugs cannot 
show therapeutic efficacy. The unwanted non-target 
accumulation and toxicity towards normal tissue are 
other major concerns. According to the classic re-
search procedure for a drug delivery development, 
scientists are supposed to initiate the studies from 
material screening, in vitro testing, and then move 
forward to in vivo (pre-clinical) measurement and 
further clinical trials. Due to the absence of an effec-
tive and accurate tool for monitoring, many agents 
which  are shown to be highly effective in vitro are 
often relatively ineffective when administered in vivo, 
sometimes they also tend to be relatively toxic and 
have unfavorable biodistribution properties. Moreo-
ver, the delay to track the features of a drug makes it 
difficult to monitor the drug fate under the physio-
logical circumstance. 
Image guided drug delivery (IGDD) is a novel 
strategy that combines the effect of therapy and visi-
bility in the drug delivery system to overcome the 
above limitations. The term of “Theranostics” en-
compasses two distinct characteristics, with both 
therapeutic and diagnostic agents on a single plat-
form. Such a theranostic system can be used to local-
ize therapeutic targets and monitor drug delivery in a 
visible way, therefore improve the therapeutic index 
and decrease systemic toxicity. The introduction of 
IGDD concept into pharmaceutical sciences will defi-
nitely speed up the research on drug R&D with an 
extremely high efficiency. This comprehensive IGDD 
system combining the properties of both therapy and 
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diagnosis possesses numerous advantages over ex-
isting treatment approaches. With the assistance from 
the development of novel materials, molecular imag-
ing probes for positron emission tomography (PET), 
single-photon emission computed tomography 
(SPECT), highly sensitive ultrasound, magnetic reso-
nance imaging (MRI), luminescence/fluorescence and 
Raman, photoacoustic imaging as well as multimodal 
imaging probes can be incorporated with drugs or 
drug carriers, facilitating the localization and quanti-
fication of radioisotope, optical probe, or other 
tag-labeled drug delivery systems in the category of 
theranostics. The variety of medical imaging tracking 
modalities will help in the development of highly 
effective delivery systems for site-specific treatment in 
a minimally invasive way, leading to enhanced un-
derstanding of cancer biology, disease mechanism 
and paths for their eradication. 
This special IGDD issue consists of five original 
research papers and one review, which are all con-
tributed from leading prominent researchers with 
international reputation in the field of theranostics. 
The findings include the synthesis and structure 
modification of the biomaterials such as chitosan, 
PLGA as well as the preparation of emulsions  and 
liposomes etc., more importantly, the development of 
these delivery systems incorporating highly sensitive 
image modalities such as X-rays, ultrasound, fluores-
cence and so on.  
The review of “Image guided biodistribution 
and pharmacokinetic studies of theranostics” gave an 
overall introduction of several existing imaging mo-
dalities that had been applied in the field of biomedi-
cine and even in clinics, including MRI, CT, PET, 
SPECT, US and fluorescence imaging. And these 
quantitative or semi-quantitative imaging modalities 
can employ high sensitive image techniques to find 
out biodistribution of the labeled drugs or probe 
loaded delivery systems in the body. These 
non-invasive imaging modalities, including MRI, ra-
dio-labeling and fluorescence etc attracted more at-
tention because of their properties of no breaking in 
the skin and no contact with the mucosa and no 
breaking through internal body cavity beyond a nat-
ural or artificial body orifice. This review also listed 
some representative applications of imaging modali-
ties in the area of biodistribution and pharmacokinet-
ics of drug delivery system for the aim of treatment 
and diagnosis. [1] Dr. Yuan et al. applied low molec-
ular weight hydroxyethyl chitosan-prednisolone 
conjugate (LMWHC-Pre, molecular weight 31k Da) 
with excellent stability and physicochemical proper-
ties for renal targeting therapy. From the help of flu-
orescence and X-rays, the in vivo results showed sig-
nificant accumulation of LMWHC-Pre in the area of 
kidneys.[2] In Dr. Agata’s work, three molecular 
weights of PLGA were chosen for in situ formation of 
implants (ISFIs) which could be used for drug deliv-
ery applications. With the help of ultrasound based 
3-D images, this study demonstrated that implant 
properties such as phase inversion, erosion, swelling 
and drug release could be tailored by altering the 
molar ratio of the polymers used in the depot formu-
lation. [3] Dr. Willmann and his colleagues applied 
US-mediated gene delivery (UMGD) to murine 
hindlimb skeletal muscle using cationic versus neutral 
microbubbles (MBs). The in vivo data showed the  
prominent advantage of cationic MBs in DNA deliv-
ery, it enhanced UMGD efficiency even at low MB 
doses. [4] Dr. Zhang’s group successfully used man-
nosylated lycorine modified lipid nano-emulsion 
formulation (M-LYC-OA-LNEs) for tumor targeting. 
The findings from their experiment illustrated that 
this formulation could be a promising delivery system 
for targeted delivery of lycorine in the diagnosis and 
treatment of cancer. [5] In Dr. Gu and his colleagues’ 
work, two types of liposomes with charged and 
PEGylated cholesterols (anionic and cationic) were 
synthesized to verify the possible effects of cholesterol 
charge, surface shielding and chemical nature in the 
liposome. With the help from fluorescence and other 
images, the in vivo anti-tumor effect experiments con-
firmed that charged liposomes presented much high-
er tumor inhibition effect than neutral liposomes. This 
report of anti-cancer effect using charged cholesterol 
liposome with/without PEGylation may provide 
deeper understanding on the liposome formulation, 
which is critical for liposome associated drug research 
and development. [6]  
All together this special issue reported the front 
line findings in the field of IGDD. The achievements 
in theranostics will encourage not only the quick di-
agnosis on disease but also facilitate the treatment 
strategy from generalized medicine towards person-
alized regimen. We sincerely appreciate all the efforts 
from authors for their contribution and experience 
sharing. All these accomplishment will definitely 
push theranostics concept in the world of pharma-
ceutical sciences and drug delivery into a new level. 
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